HeraMED Limited Price Chart
HeraMED Limited HMD.XA Financial and Trading Overview
| HeraMED Limited stock price | 0.02 AUD |
| Previous Close | 0.07 AUD |
| Open | 0.07 AUD |
| Bid | 0.06 AUD x N/A |
| Ask | 0.07 AUD x N/A |
| Day's Range | 0.07 - 0.07 AUD |
| 52 Week Range | 0.07 - 0.22 AUD |
| Volume | 98.64K AUD |
| Avg. Volume | 21.27K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.184335 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.047 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HMD.XA Valuation Measures
| Enterprise Value | 14.04M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.4166665 |
| Enterprise Value/Revenue | 64.133 |
| Enterprise Value/EBITDA | -4.436 |
Trading Information
HeraMED Limited Stock Price History
| Beta (5Y Monthly) | 0.184335 |
| 52-Week Change | -32.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.22 AUD |
| 52 Week Low | 0.07 AUD |
| 50-Day Moving Average | 0.11 AUD |
| 200-Day Moving Average | 0.13 AUD |
HMD.XA Share Statistics
| Avg. Volume (3 month) | 21.27K AUD |
| Avg. Daily Volume (10-Days) | 28.23K AUD |
| Shares Outstanding | N/A |
| Float | 187.94M |
| Short Ratio | N/A |
| % Held by Insiders | 35.27% |
| % Held by Institutions | 2.03% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1453.020% |
| Gross Margin | 64.24% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.46% |
| Return on Equity (ttm) | -354.23% |
Income Statement
| Revenue (ttm) | 218.92K AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | 20.59% |
| Gross Profit (ttm) | 140.63K AUD |
| EBITDA | -3165248 AUD |
| Net Income Avi to Common (ttm) | -4880663 AUD |
| Diluted EPS (ttm) | -0.047 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.64M AUD |
| Total Cash Per Share (mrq) | 0.01 AUD |
| Total Debt (mrq) | 178.15K AUD |
| Total Debt/Equity (mrq) | 6.23 AUD |
| Current Ratio (mrq) | 3.851 |
| Book Value Per Share (mrq) | 0.012 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2560313 AUD |
| Levered Free Cash Flow (ttm) | -2998983 AUD |
Profile of HeraMED Limited
| Country | Australia |
| State | N/A |
| City | Netanya |
| Address | 4 Hazoran Street |
| ZIP | 4250604 |
| Phone | N/A |
| Website | https://www.hera-med.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.
Q&A For HeraMED Limited Stock
What is a current HMD.XA stock price?
HeraMED Limited HMD.XA stock price today per share is 0.02 AUD.
How to purchase HeraMED Limited stock?
You can buy HMD.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HeraMED Limited?
The stock symbol or ticker of HeraMED Limited is HMD.XA.
How many shares does HeraMED Limited have in circulation?
The max supply of HeraMED Limited shares is 0.
What is HeraMED Limited Price to Earnings Ratio (PE Ratio)?
HeraMED Limited PE Ratio is now.
What was HeraMED Limited earnings per share over the trailing 12 months (TTM)?
HeraMED Limited EPS is -0.047 AUD over the trailing 12 months.